Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of remazolam for anesthesia induction during endoscopic submucosal dissection in elderly patients
ChiCTR2500110937Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam mesylate in gastric cancer (GC), sponsored by Shanghai East Hospital. Primary endpoints: ED50 and ED95. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
remimazolam mesylate
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2500110937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110937.